Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
6,545,782
-
Share change
-
-1,747,704
-
Total reported value
-
$20,956,481
-
Put/Call ratio
-
105%
-
Price per share
-
$3.20
-
Number of holders
-
69
-
Value change
-
-$4,999,225
-
Number of buys
-
30
-
Number of sells
-
35
Institutional Holders of GALECTIN THERAPEUTICS INC - COM NEW (GALT) as of Q2 2021
As of 30 Jun 2021,
GALECTIN THERAPEUTICS INC - COM NEW (GALT) was held by
69 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
6,545,782 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock Inc., MILLENNIUM MANAGEMENT LLC, Geneos Wealth Management Inc., GEODE CAPITAL MANAGEMENT, LLC, RENAISSANCE TECHNOLOGIES LLC, Cutter & CO Brokerage, Inc., Cambridge Investment Research Advisors, Inc., STATE STREET CORP, and Ergoteles LLC.
This page lists
69
institutional shareholders reporting positions in this security
for the Q2 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.